Clinical Trials

Clinical Trials

Clinical Trial Number: RESTORE
Find a Doctor

REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Study ID: RESTORE
Phase N/A
Physician Investigator(s)
Study Locations

Contact Us

484.476.8425
chandardate@mlhs.org

The purpose of this study is to generate clinical evidence on valve safety and performance in subjects treated by redo Transcatheter Aortic Valve Replacement (TAVR).

Learn More

Eligibility Criteria

Inclusion Criteria:

  • BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR

Exclusion Criteria:

  • BVF due solely to paravalvular regurgitation
  • Active endocarditis
  • Untreated acute valve thrombosis
  • Life-expectancy less than 1-year
  • Subject is less than legal age of consent, legally incompetent, or otherwise vulnerable
  • Participating in another study that may influence the outcome of this study